CANCER: Second-line chemotherapy patients benefit from vandetanibDrop of 21% in risk of disease progression seen after 13-month followup CANCER: Pemetrexed boosts non-small cell survival ratesPatients with nonsquamous cell carcinoma live up to 5.2 months longer, research shows Income gap in Ontario cancer screening Low rate of follow-up care to abnormal Pap tests Annual screening for skin cancer: Reasons for non-compliance Ovary removal linked to higher risk of lung cancer Canadian researcher says result is preliminary, but intriguing Breast cancer testing to restart Ovarian Cancer Helping patients navigate treatment courses and manage side effects CANCER: North American chemo standard tops European standard for pancreatic cancer Gemcitabine offers fewer side-effects than 5-FU/FA, with same survival CANCER: Drug may reduce distant metastases in rectal cancer Mutant cows make anti-carcinogenic milk First Previous 71 72 73 74 75 Next Last
